Serum antibodies and anthropometric data at diagnosis in pediatric crohn's disease

Anna K. Trauernicht, Steven Steiner

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background Serum antibodies, including ASCA, anti- OmpC, and ANCA, correlate with disease location and predict disease phenotype in inflammatory bowel disease. Aim The objective of this study was to determine relationships between serum antibody status and anthropometric data for children with newly diagnosed Crohn's disease. Methods A retrospective review was conducted on children diagnosed with Crohn's disease at our institution from 2003 to 2008. Patients who had ASCA IgA, ASCA IgG, anti-OmpC, and pANCA antibodies, and anthropometric data measured before diagnosis and therapy were included. Z-scores for height and weight were compared among groups according to the presence of specific antibodies. Spearman's rank correlation was used to assess association between antibodies and growth data. Results One hundred and two patients, mean age 11.9 years, met the inclusion criteria. Patients with the presence of any of the four antibodies had lower mean height and weight z-scores than patients without any antibodies present. When individual antibodies were studied, patients with positive ASCA titers had lower mean weight and height z-scores than patients without any antibodies present. Spearman's rank correlation coefficient demonstrated a significant association between increasing ASCA titers and lower weight z-scores, but not lower height z-scores. Conclusions Pediatric patients with newly diagnosed Crohn's disease and the presence of ASCA antibodies have lower mean height and weight z-scores. This study provides evidence that specific subsets of children with Crohn's disease may be at greater risk of growth impairment.

Original languageEnglish
Pages (from-to)1020-1025
Number of pages6
JournalDigestive Diseases and Sciences
Volume57
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Antibodies
Serum
Crohn Disease
Weights and Measures
Pediatric Crohn's disease
Antineutrophil Cytoplasmic Antibodies
Growth
Nonparametric Statistics
Inflammatory Bowel Diseases
Immunoglobulin A
Pediatrics
Phenotype

Keywords

  • Anthropometry
  • Crohn's disease
  • Growth
  • Pediatrics

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Serum antibodies and anthropometric data at diagnosis in pediatric crohn's disease. / Trauernicht, Anna K.; Steiner, Steven.

In: Digestive Diseases and Sciences, Vol. 57, No. 4, 04.2012, p. 1020-1025.

Research output: Contribution to journalArticle

@article{2d847d96cd6141fc8b2657c96c09785e,
title = "Serum antibodies and anthropometric data at diagnosis in pediatric crohn's disease",
abstract = "Background Serum antibodies, including ASCA, anti- OmpC, and ANCA, correlate with disease location and predict disease phenotype in inflammatory bowel disease. Aim The objective of this study was to determine relationships between serum antibody status and anthropometric data for children with newly diagnosed Crohn's disease. Methods A retrospective review was conducted on children diagnosed with Crohn's disease at our institution from 2003 to 2008. Patients who had ASCA IgA, ASCA IgG, anti-OmpC, and pANCA antibodies, and anthropometric data measured before diagnosis and therapy were included. Z-scores for height and weight were compared among groups according to the presence of specific antibodies. Spearman's rank correlation was used to assess association between antibodies and growth data. Results One hundred and two patients, mean age 11.9 years, met the inclusion criteria. Patients with the presence of any of the four antibodies had lower mean height and weight z-scores than patients without any antibodies present. When individual antibodies were studied, patients with positive ASCA titers had lower mean weight and height z-scores than patients without any antibodies present. Spearman's rank correlation coefficient demonstrated a significant association between increasing ASCA titers and lower weight z-scores, but not lower height z-scores. Conclusions Pediatric patients with newly diagnosed Crohn's disease and the presence of ASCA antibodies have lower mean height and weight z-scores. This study provides evidence that specific subsets of children with Crohn's disease may be at greater risk of growth impairment.",
keywords = "Anthropometry, Crohn's disease, Growth, Pediatrics",
author = "Trauernicht, {Anna K.} and Steven Steiner",
year = "2012",
month = "4",
doi = "10.1007/s10620-011-1954-x",
language = "English",
volume = "57",
pages = "1020--1025",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Serum antibodies and anthropometric data at diagnosis in pediatric crohn's disease

AU - Trauernicht, Anna K.

AU - Steiner, Steven

PY - 2012/4

Y1 - 2012/4

N2 - Background Serum antibodies, including ASCA, anti- OmpC, and ANCA, correlate with disease location and predict disease phenotype in inflammatory bowel disease. Aim The objective of this study was to determine relationships between serum antibody status and anthropometric data for children with newly diagnosed Crohn's disease. Methods A retrospective review was conducted on children diagnosed with Crohn's disease at our institution from 2003 to 2008. Patients who had ASCA IgA, ASCA IgG, anti-OmpC, and pANCA antibodies, and anthropometric data measured before diagnosis and therapy were included. Z-scores for height and weight were compared among groups according to the presence of specific antibodies. Spearman's rank correlation was used to assess association between antibodies and growth data. Results One hundred and two patients, mean age 11.9 years, met the inclusion criteria. Patients with the presence of any of the four antibodies had lower mean height and weight z-scores than patients without any antibodies present. When individual antibodies were studied, patients with positive ASCA titers had lower mean weight and height z-scores than patients without any antibodies present. Spearman's rank correlation coefficient demonstrated a significant association between increasing ASCA titers and lower weight z-scores, but not lower height z-scores. Conclusions Pediatric patients with newly diagnosed Crohn's disease and the presence of ASCA antibodies have lower mean height and weight z-scores. This study provides evidence that specific subsets of children with Crohn's disease may be at greater risk of growth impairment.

AB - Background Serum antibodies, including ASCA, anti- OmpC, and ANCA, correlate with disease location and predict disease phenotype in inflammatory bowel disease. Aim The objective of this study was to determine relationships between serum antibody status and anthropometric data for children with newly diagnosed Crohn's disease. Methods A retrospective review was conducted on children diagnosed with Crohn's disease at our institution from 2003 to 2008. Patients who had ASCA IgA, ASCA IgG, anti-OmpC, and pANCA antibodies, and anthropometric data measured before diagnosis and therapy were included. Z-scores for height and weight were compared among groups according to the presence of specific antibodies. Spearman's rank correlation was used to assess association between antibodies and growth data. Results One hundred and two patients, mean age 11.9 years, met the inclusion criteria. Patients with the presence of any of the four antibodies had lower mean height and weight z-scores than patients without any antibodies present. When individual antibodies were studied, patients with positive ASCA titers had lower mean weight and height z-scores than patients without any antibodies present. Spearman's rank correlation coefficient demonstrated a significant association between increasing ASCA titers and lower weight z-scores, but not lower height z-scores. Conclusions Pediatric patients with newly diagnosed Crohn's disease and the presence of ASCA antibodies have lower mean height and weight z-scores. This study provides evidence that specific subsets of children with Crohn's disease may be at greater risk of growth impairment.

KW - Anthropometry

KW - Crohn's disease

KW - Growth

KW - Pediatrics

UR - http://www.scopus.com/inward/record.url?scp=84864040908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864040908&partnerID=8YFLogxK

U2 - 10.1007/s10620-011-1954-x

DO - 10.1007/s10620-011-1954-x

M3 - Article

C2 - 22075854

AN - SCOPUS:84864040908

VL - 57

SP - 1020

EP - 1025

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 4

ER -